fast crypto coin- Top searches

Federal Reserve's December OutlookThe latest progress of stamp duty in Hong Kong has come!At present, there is nothing wrong with the medium and long-term trend, so don't worry too much. Strategically, we will continue to watch more. Tactically, we will follow the trend and take the initiative step by step.

The latest CPI data will be released tonight. The market expects the overall inflation rate to be 2.7%, 0.1 percentage point higher than that in October, and the core inflation rate is expected to be 3.3%, which is the same as that in October. Although the forecast data shows that the suppression of inflation by monetary policy is close to stagnation, it has dropped sharply compared with the previous peak of 9%. At present, the latest FEDWATCH data shows that the possibility of the Fed cutting interest rates next Tuesday is over 80%.So will heavyweights and large-cap stocks exert their strength? Looking at the trend of SSE 50, it is still very possible, because at present, the monthly trend of SSE 50 index is intact, and the index remains above the offensive line and above the long-term trend line. At present, it has the foundation to start a big market. Looking back, the index must remain above the monthly offensive line in all big markets, so this is a prerequisite. Since it is also available now, we can certainly expect something.At present, there is nothing wrong with the medium and long-term trend, so don't worry too much. Strategically, we will continue to watch more. Tactically, we will follow the trend and take the initiative step by step.

21st century business herald reporter learned exclusively from insiders that this week, the personal pension expansion policy will be announced, "the time may be December 12th". It is reported that the investable products included in personal pension may include over-the-counter products tracking nearly 20 broad-based indexes such as Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI 800 Index, GEM Index and Kechuang 50 Index.Dezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.Federal Reserve's December Outlook